Bevin is a research associate currently working in two research areas: 1) using proteomics to identify and validate novel serum/plasma biomarker candidates for liver diseases including fatty liver disease1,2,3,4,5,6,7,8 and 2) working with the VIE team evaluating methods to assess substandard and falsified vaccines9. He carried out his DPhil in the Zitzmann lab where he identified serum biomarker candidates for liver fibrosis10.
Before joining the Zitzmann group he obtained his BSc (Hon) in Medical Biochemistry at the University of Surrey with his dissertation on investigating different membrane compositions for the optimisation of biosensors11. During his BSc he carried out his Professional Training at SmithKline Beecham and GlaxoSmithKline where he looked at ways of improving the representation of low abundant plasma proteins by depleting high abundant proteins and also compared different protein gel stains12.
Bevin works with others in the group and collaborators to help use proteomics to investigate several viral systems. This includes HCV13, hepatitis B virus14, herpes simplex virus15, HIV16, COVID-1917, Japanese encephalitis18 and Hazara virus19. Bevin is also on the editorial board for Biomarker Research and gives proteomics lectures to students in the department.